MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

Simulations Plus Inc

Cerrado

SectorSanidad

14.99 5.05

Resumen

Variación precio

24h

Actual

Mínimo

14.15

Máximo

14.99

Métricas clave

By Trading Economics

Ingresos

3.9M

4.5M

Ventas

5.9M

24M

BPA

0.35

Rentabilidad por dividendo

0.48

Margen de beneficios

18.669

Empleados

212

EBITDA

4.9M

7.2M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+63.54% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.38%

Próximas Ganancias

13 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

11M

262M

Apertura anterior

9.94

Cierre anterior

14.99

Noticias sobre sentimiento de mercado

By Acuity

20%

80%

55 / 348 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

20 abr 2026, 23:49 UTC

Noticias de Eventos Importantes

New Zealand 1Q Inflation Higher Than Expected

20 abr 2026, 23:10 UTC

Acciones populares

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20 abr 2026, 22:53 UTC

Principales Movimientos del Mercado

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20 abr 2026, 23:45 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20 abr 2026, 23:44 UTC

Charlas de Mercado

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20 abr 2026, 23:39 UTC

Charlas de Mercado

Rio Tinto Posts Strong Start to Year -- Market Talk

20 abr 2026, 23:30 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

20 abr 2026, 23:30 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

20 abr 2026, 23:30 UTC

Charlas de Mercado

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20 abr 2026, 23:09 UTC

Charlas de Mercado

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20 abr 2026, 22:31 UTC

Adquisiciones, fusiones, absorciones

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 abr 2026, 22:26 UTC

Adquisiciones, fusiones, absorciones

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20 abr 2026, 22:25 UTC

Adquisiciones, fusiones, absorciones

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20 abr 2026, 22:25 UTC

Adquisiciones, fusiones, absorciones

West African Resources Aims for Acquisition to Be Completed by End-2026

20 abr 2026, 22:25 UTC

Adquisiciones, fusiones, absorciones

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20 abr 2026, 22:25 UTC

Adquisiciones, fusiones, absorciones

West African Resources Says Acquisition Would Be for A$175 Million

20 abr 2026, 22:24 UTC

Adquisiciones, fusiones, absorciones

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20 abr 2026, 22:15 UTC

Adquisiciones, fusiones, absorciones

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20 abr 2026, 22:01 UTC

Adquisiciones, fusiones, absorciones

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20 abr 2026, 21:38 UTC

Charlas de Mercado

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20 abr 2026, 21:33 UTC

Adquisiciones, fusiones, absorciones

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20 abr 2026, 21:24 UTC

Charlas de Mercado

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20 abr 2026, 21:24 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

20 abr 2026, 21:13 UTC

Ganancias

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20 abr 2026, 21:10 UTC

Ganancias

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20 abr 2026, 21:09 UTC

Ganancias

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20 abr 2026, 21:08 UTC

Ganancias

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20 abr 2026, 21:07 UTC

Ganancias

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20 abr 2026, 21:05 UTC

Ganancias

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20 abr 2026, 21:05 UTC

Ganancias

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

63.54% repunte

Estimación a 12 Meses

Media 23.5 USD  63.54%

Máximo 31 USD

Mínimo 16 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

55 / 348 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat